In addition, the expression of SERBP1 is down-regulated by 38% in epilepsy model mice, and restoring SERBP1 expression can reduce the frequency of epileptic seizures by decreasing the KCC2 level, confirming the potential therapeutic value of SERBP1 in nervous system diseases [13]. This evidence concerns the gene SERBP1 and nervous system disorder.